ArticlePloS one2021

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.

Kiyomi Mashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.